Suzanne George

Suzanne George

UNVERIFIED PROFILE

Are you Suzanne George?   Register this Author

Register author
Suzanne George

Suzanne George

Publications by authors named "Suzanne George"

Are you Suzanne George?   Register this Author

99Publications

2595Reads

25Profile Views

Intrigue: Phase III study of ripretinib versus sunitinib in advanced gastrointestinal stromal tumor after imatinib.

Future Oncol 2020 Jan 22;16(1):4251-4264. Epub 2019 Nov 22.

Portland VA Health Care System & OHSU Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97239, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon-2019-0633DOI Listing
January 2020

Characteristics of mismatch repair deficiency in sarcomas.

Mod Pathol 2019 07 14;32(7):977-987. Epub 2019 Feb 14.

Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/s41379-019-0202-3
Publisher Site
http://dx.doi.org/10.1038/s41379-019-0202-3DOI Listing
July 2019

Developments in Systemic Therapy for Soft Tissue and Bone Sarcomas.

Authors:
Suzanne George

J Natl Compr Canc Netw 2019 May;17(5.5):625-628

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2019.5020DOI Listing
May 2019

Low Levels of Evidence for Neoadjuvant Chemotherapy to Treat Soft-Tissue Sarcoma.

JAMA Oncol 2018 09;4(9):1169-1170

Department of Medical Oncology, Center for Sarcoma and Bone Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2018.1403DOI Listing
September 2018

Soft Tissue and Uterine Leiomyosarcoma.

J Clin Oncol 2018 01 8;36(2):144-150. Epub 2017 Dec 8.

Suzanne George, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; César Serrano, Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Barcelona, Spain; Martee L. Hensley, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, NY; and Isabelle Ray-Coquard, Centre Leon Berard and University Claude-Bernard, Lyon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.75.9845DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5759317PMC
January 2018

YWHAE-rearranged high-grade endometrial stromal sarcoma: Two-center case series and response to chemotherapy.

Gynecol Oncol 2017 06 5;145(3):531-535. Epub 2017 Apr 5.

Center for Sarcoma and Bone Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2017.03.021DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5471810PMC
June 2017

Novel Insights into the Treatment of Imatinib-Resistant Gastrointestinal Stromal Tumors.

Target Oncol 2017 06;12(3):277-288

Department of Medical Oncology, Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, P. Vall d'Hebron 119, 08035, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11523-017-0490-9DOI Listing
June 2017

Evolving Treatment of Soft Tissue Sarcoma.

Authors:
Suzanne George

J Natl Compr Canc Netw 2017 05;15(5S):733-736

Presented by Suzanne George, MD, Center for Sarcoma and Bone Oncology, Dana-Farber/Brigham and Women's Cancer Center, and Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2017.0087DOI Listing
May 2017

Role of Imaging in Management of Desmoid-type Fibromatosis: A Primer for Radiologists.

Radiographics 2016 May-Jun;36(3):767-82

From the Department of Imaging, Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Ave, Boston, MA 02215 (M.B.A., A.R.K., K.M.K., S.H.T., A.B.S., N.H.R., J.P.J.); Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Mass (M.B.A., A.R.K., K.M.K., S.H.T., A.B.S., N.H.R., J.P.J.); Department of Pathology, Brigham and Women's Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, Mass (J.L.H.); Department of Radiation Oncology, Brigham and Women's Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, Mass (E.H.B.); and Center for Sarcoma and Bone Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Mass (S.G.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1148/rg.2016150153DOI Listing
March 2017

Surgical Management of Wild-Type Gastrointestinal Stromal Tumors: A Report From the National Institutes of Health Pediatric and Wildtype GIST Clinic.

J Clin Oncol 2017 Feb 28;35(5):523-528. Epub 2016 Dec 28.

Christopher B. Weldon and Arin L. Madenci, Boston Children's Hospital; Christopher B. Weldon, Arin L. Madenci, Katherine A. Janeway, and Suzanne George, Harvard Medical School; Christopher B. Weldon, Katherine A. Janeway, and Suzanne George, Dana-Farber/Boston Children's Cancer and Blood Disorders Center; Arin L. Madenci, Brigham and Women's Hospital, Boston, MA; Sosipatros A. Boikos, Massey Cancer Center, Virginia Commonwealth University, Richmond, VA; Margaret von Mehren, Fox Chase Cancer Center, Philadelphia, PA; Alberto S. Pappo, St Jude Children's Research Hospital, Memphis, TN; Joshua D. Schiffman and Jennifer Wright, Huntsman Cancer Institute, Salt Lake City, UT; Jonathan C. Trent, Sylvester Comprehensive Cancer Center, Miami, FL; Karel Pacak and Constantine A. Stratakis, Eunice Kennedy Shriver National Institute of Child Health and Human Development; Lee J. Helman, National Cancer Institute, Bethesda, MD; and Michael P. La Quaglia, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.68.6733DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455315PMC
February 2017

Loss of PTEN Is Associated with Resistance to Anti-PD-1 Checkpoint Blockade Therapy in Metastatic Uterine Leiomyosarcoma.

Immunity 2017 02;46(2):197-204

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Center for Cancer Precision Medicine, Dana-Farber Cancer Institute, Boston, MA 02215, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.immuni.2017.02.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5408320PMC
February 2017

Comparison of performance of various tumor response criteria in assessment of sunitinib activity in advanced gastrointestinal stromal tumors.

Clin Imaging 2016 Sep-Oct;40(5):880-4. Epub 2016 Apr 26.

Department of Imaging, Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA 02215, USA; Department of Radiology, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clinimag.2016.04.007DOI Listing
December 2016

New Approaches to Managing Liposarcoma: Will Cold Steel Remain the Only Way to Heal?

J Oncol Pract 2016 Mar;12(3):230-1

Dana-Farber Cancer Institute, Boston, MA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.2015.010280DOI Listing
March 2016

Solitary Fibrous Tumor of the Uterus Presenting With Lung Metastases: A Case Report.

Int J Gynecol Pathol 2016 Jan;35(1):25-9

Division of Women's and Perinatal Pathology (K.C.S., M.R.N., B.E.H.) Department of Obstetrics and Gynecology, Division of Gynecologic Pathology, Brigham and Women's Hospital (K.M.E., M.G.M.) Department of Medical Oncology, Dana-Farber Cancer Institute (S.C., S.G.), Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PGP.0000000000000197DOI Listing
January 2016

Risk Factors for Occult Uterine Sarcoma Among Women Undergoing Minimally Invasive Gynecologic Surgery.

J Minim Invasive Gynecol 2016 Jan 4;23(1):34-9. Epub 2015 Aug 4.

Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Brigham and Women's Hospital, Boston, MA; Harvard School of Medicine, Boston, MA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15534650150054
Publisher Site
http://dx.doi.org/10.1016/j.jmig.2015.07.017DOI Listing
January 2016

Uterine Sarcoma, Version 1.2016: Featured Updates to the NCCN Guidelines.

J Natl Compr Canc Netw 2015 Nov;13(11):1321-31

From Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance; University of Washington/Seattle Cancer Care Alliance; Memorial Sloan Kettering Cancer Center; Moffitt Cancer Center; Dana-Farber/Brigham and Women's Cancer Center; University of Michigan Comprehensive Cancer Center; Fox Chase Cancer Center; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute; Vanderbilt-Ingram Cancer Center; Massachusetts General Hospital Cancer Center; Stanford Cancer Institute; The University of Texas MD Anderson Cancer Center; University of Colorado Cancer Center; Roswell Park Cancer Institute; Huntsman Cancer Institute at the University of Utah; City of Hope Comprehensive Cancer Center; Yale Cancer Center/Smilow Cancer Hospital; University of Alabama at Birmingham Comprehensive Cancer Center; Robert H. Lurie Comprehensive Cancer Center of Northwestern University; Mayo Clinic Cancer Center; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Fred & Pamela Buffet Cancer Center at The Nebraska Medical Center; St. Jude Children's Research Hospital/The University of Tennessee Health Science Center; Duke Cancer Institute; UC San Diego Moores Cancer Center; and National Comprehensive Cancer Network.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2015.0162DOI Listing
November 2015

Template for Reporting Results of Biomarker Testing of Specimens From Patients With Gastrointestinal Stromal Tumors.

Arch Pathol Lab Med 2015 Oct 2;139(10):1271-5. Epub 2015 Mar 2.

From Surgical Pathology, Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York (Drs Hameed and Tang); the Department of Pathology, Oregon Health & Science University, Portland (Dr Corless); the Center for Sarcoma and Bone Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts (Dr George); the Department of Pathology, Brigham and Women's Hospital, Boston (Dr Hornick); the Department of Pathology, University of California, San Francisco, and the Veterans Affairs Medical Center, San Francisco (Dr Kakar); and the Department of Pathology, Sarcoma Research Center, University of Texas MD Anderson Cancer Center, Houston (Dr Lazar).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2014-0578-CPDOI Listing
October 2015

Biologic Activity of Autologous, Granulocyte-Macrophage Colony-Stimulating Factor Secreting Alveolar Soft-Part Sarcoma and Clear Cell Sarcoma Vaccines.

Clin Cancer Res 2015 Jul 24;21(14):3178-86. Epub 2015 Mar 24.

Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. Cancer Vaccine Center, Center for Immuno-oncology, and Melanoma Disease Center, Dana-Farber Cancer Institute, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-14-2932DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4506240PMC
July 2015

Whole Lung Irradiation in Adults with Metastatic Ewing Sarcoma: Practice Patterns and Implications for Treatment.

Sarcoma 2015 25;2015:591698. Epub 2015 Jun 25.

Center for Sarcoma and Bone Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA ; Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA ; Department of Radiation Oncology, Brigham and Women's Hospital, Boston, MA 02115, USA ; Department of Radiation Oncology, Boston's Children's Hospital, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2015/591698DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4496475PMC
July 2015

Serum NSE level and disability progression in multiple sclerosis.

J Neurol Sci 2015 Mar 11;350(1-2):46-50. Epub 2015 Feb 11.

Department of Clinical Neurosciences and Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jns.2015.02.009DOI Listing
March 2015

Gastrointestinal stromal tumor: optimizing the use of cross-sectional chest imaging during follow-up.

Radiology 2015 Feb 5;274(2):395-404. Epub 2014 Sep 5.

From the Department of Radiology and Center for Evidence-Based Imaging, Brigham and Women's Hospital, Harvard Medical School, 75 Francis St, Boston, MA 02115 (A.B.S., I.K.I., R.L., R.K.); Department of Radiology, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Boston, Mass (A.B.S., N.H.R.); and Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Mass (S.G.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1148/radiol.14132456DOI Listing
February 2015

Reply to in-bag morcellation for presumed myoma retrieval at laparoscopy.

Cancer 2014 Dec 7;120(24):4005. Epub 2014 Aug 7.

Center for Sarcoma and Bone Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.28957DOI Listing
December 2014

Retrospective cohort study evaluating the impact of intraperitoneal morcellation on outcomes of localized uterine leiomyosarcoma.

Cancer 2014 Oct 12;120(20):3154-8. Epub 2014 Jun 12.

Center for Sarcoma and Bone Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.28844DOI Listing
October 2014

Metastatic pattern of uterine leiomyosarcoma: retrospective analysis of the predictors and outcome in 113 patients.

J Gynecol Oncol 2014 Oct 5;25(4):306-12. Epub 2014 Aug 5.

Department of Imaging, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
https://synapse.koreamed.org/DOIx.php?id=10.3802/jgo.2014.25
Publisher Site
http://dx.doi.org/10.3802/jgo.2014.25.4.306DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4195301PMC
October 2014

Clinical outcomes of women with recurrent or persistent uterine leiomyosarcoma.

Int J Gynecol Cancer 2014 Oct;24(8):1434-40

*Division of Gynecologic Oncology, Vincent Obstetrics and Gynecology, Massachusetts General Hospital, †Division of Gynecologic Oncology, Brigham and Women's Hospital, and ‡Dana Farber Cancer Institute, Harvard Medical School, Boston, MA.

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/ijgc/2014/10000/Clinical_Outcom
Web Search
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/IGC.0000000000000221DOI Listing
October 2014

Optimizing treatment outcomes with regorafenib: personalized dosing and other strategies to support patient care.

Oncologist 2014 Jun 12;19(6):669-80. Epub 2014 May 12.

Mayo Clinic, Rochester, Minnesota, USA; Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA; University Hospital Gasthuisberg/Leuven, Leuven, Belgium; Léon Bérard Centre and Claude Bernard University, Lyon, France; IRCCS San Martino, Genoa, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2013-0059DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4041675PMC
June 2014

Gastrointestinal stromal tumors, version 2.2014.

J Natl Compr Canc Netw 2014 Jun;12(6):853-62

From Fox Chase Cancer Center; Huntsman Cancer Institute at the University of Utah; The University of Texas MD Anderson Cancer Center; UC San Diego Moores Cancer Center; Moffitt Cancer Center; Memorial Sloan-Kettering Cancer Center; Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance; Massachusetts General Hospital Cancer Center; Stanford Cancer Institute; Dana-Farber/Brigham and Women's Cancer Center; University of Alabama at Birmingham Comprehensive Cancer Center; Roswell Park Cancer Institute; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute; Fred & Pamela Buffett Cancer Center at The Nebraska Medical Center; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; UCSF Helen Diller Family Comprehensive Cancer Center; St. Jude Children's Research Hospital/The University of Tennessee Health Science Center; City of Hope Comprehensive Cancer Center; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; Duke Cancer Institute; University of Michigan Comprehensive Cancer Center; Vanderbilt-Ingram Cancer Center; Robert H. Lurie Comprehensive Cancer Center of Northwestern University; and National Comprehensive Cancer Network.

View Article

Download full-text PDF

Source
http://www.jnccn.org/content/12/6/853.full.pdf
Web Search
http://dx.doi.org/10.6004/jnccn.2014.0080DOI Listing
June 2014

Desmoid-type fibromatosis and pregnancy: a multi-institutional analysis of recurrence and obstetric risk.

Ann Surg 2014 May;259(5):973-8

*Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy †Department of Surgery, Institut Gustave Roussy, Villejuif, France ‡Division of General Surgery, Mount Sinai Hospital; Department of Surgical Oncology, Princess Margaret Hospital; and Department of Surgery, University of Toronto, Toronto, Ontario, Canada §Department of Surgery, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA ¶Department of Medical Oncology, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA ‖Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France **Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/annalsofsurgery/2014/05000/Desm
Web Search
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/SLA.0000000000000224DOI Listing
May 2014

Recent advances in the treatment of gastrointestinal stromal tumors.

Ther Adv Med Oncol 2014 May;6(3):115-27

Center for Sarcoma and Bone Oncology, Dana-Farber Cancer Institute/Harvard Medical School, 450 Brookline Ave., Boston, MA 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1758834014522491DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3987653PMC
May 2014

Soft tissue sarcoma, version 2.2014.

J Natl Compr Canc Netw 2014 Apr;12(4):473-83

From 1Fox Chase Cancer Center; 2Huntsman Cancer Institute at the University of Utah; 3The University of Texas MD Anderson Cancer Center; 4UC San Diego Moores Cancer Center; 5Moffitt Cancer Center; 6Memorial Sloan-Kettering Cancer Center; 7Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance; 8Massachusetts General Hospital Cancer Center; 9Stanford Cancer Institute; 10Dana-Farber/Brigham and Women's Cancer Center; 11University of Alabama at Birmingham Comprehensive Cancer Center; 12Roswell Park Cancer Institute; 13The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute; 14Fred & Pamela Buffett Cancer Center at The Nebraska Medical Center; 15The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; 16UCSF Helen Diller Family Comprehensive Cancer Center; 17St. Jude Children's Research Hospital/The University of Tennessee Health Science Center; 18City of Hope Comprehensive Cancer Center; 19Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; 20Duke Cancer Institute; 21University of Michigan Comprehensive Cancer Center; 22Vanderbilt-Ingram Cancer Center; 23Robert H. Lurie Comprehensive Cancer Center of Northwestern University; and 24National Comprehensive Cancer Network.

View Article

Download full-text PDF

Source
http://www.jnccn.org/content/12/4/473.full.pdf
Web Search
http://dx.doi.org/10.6004/jnccn.2014.0053DOI Listing
April 2014

Comparison of performance of various tumour response criteria in assessment of regorafenib activity in advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib.

Eur J Cancer 2014 Mar 2;50(5):981-6. Epub 2014 Jan 2.

Department of Imaging, Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA 02215, United States; Department of Radiology, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02215, United States; Ludwig Center and Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA 02215, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2013.11.037DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4242716PMC
March 2014

Synchronous small bowel and atypical primary leiomyosarcoma of inferior vena cava in a patient with RB1 mutation.

Abdom Imaging 2014 Feb;39(1):33-9

Department of Radiology, Dana Farber Cancer Institute & Harvard Medical School, 450 Brookline Avenue, Boston, MA, 02215, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00261-012-9904-4DOI Listing
February 2014

The value of re-exploration in patients with inadvertently morcellated uterine sarcoma.

Gynecol Oncol 2014 Feb 1;132(2):360-5. Epub 2013 Dec 1.

Division of Gynecologic Oncology, Brigham and Women's Hospital, Boston, MA, United States; Harvard School of Medicine, Boston, MA, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2013.11.024DOI Listing
February 2014

Adolescent and young adult oncology, version 2.2014.

J Natl Compr Canc Netw 2014 Jan;12(1):21-32; quiz 32

From 1Fred & Pamela Buffett Cancer Center at The Nebraska Medical Center; 2St. Jude Children's Research Hospital/The University of Tennessee Health Science Center; 3Robert H. Lurie Comprehensive Cancer Center of Northwestern University; 4City of Hope Comprehensive Cancer Center; 5Vanderbilt-Ingram Cancer Center; 6The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute; 7Dana-Farber/Brigham and Women's Cancer Center; 8UCSF Helen Diller Family Comprehensive Cancer Center; 9Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; 10Massachusetts General Hospital Cancer Center; 11Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance; 12Roswell Park Cancer Institute; 13Stanford Cancer Institute; 14Memorial Sloan-Kettering Cancer Center; 15The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; 16Moffitt Cancer Center; 17Huntsman Cancer Institute at the University of Utah; 18The University of Texas MD Anderson Cancer Center; 19Fox Chase Cancer Center; 20Duke Cancer Institute; 21University of Alabama at Birmingham Comprehensive Cancer Center; 22University of Michigan Comprehensive Cancer Center; and 23National Comprehensive Cancer Network.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2014.0004DOI Listing
January 2014

A phase I study of the HSP90 inhibitor retaspimycin hydrochloride (IPI-504) in patients with gastrointestinal stromal tumors or soft-tissue sarcomas.

Clin Cancer Res 2013 Nov 17;19(21):6020-9. Epub 2013 Sep 17.

Authors' Affiliations: Dana-Farber Cancer Institute and Harvard Medical School; Ludwig Center at Dana-Farber/Harvard Cancer Center, Boston, Massachusetts; University of Michigan, Ann Arbor, Michigan; UCLA Division of Hematology-Oncology, Santa Monica, California; Pinnacle Oncology, Scottsdale, Arizona; and Infinity Pharmaceuticals, Inc., Cambridge, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-13-0953DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4330562PMC
November 2013

Leiomyosarcoma.

Hematol Oncol Clin North Am 2013 Oct 26;27(5):957-74. Epub 2013 Aug 26.

Fletcher Laboratory, Department of Pathology, Brigham and Women's Hospital, 75 Francis Street, Thorn 528, Boston, MA 02115, USA; Center for Sarcoma and Bone Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.hoc.2013.07.002DOI Listing
October 2013

Uterine leiomyosarcoma: an updated series.

Int J Gynecol Cancer 2013 Jul;23(6):1036-43

Division of Gynecologic Oncology, Vincent Obstetrics and Gynecology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/IGC.0b013e31829590dcDOI Listing
July 2013

MED12 mutations in leiomyosarcoma and extrauterine leiomyoma.

Mod Pathol 2013 May 7;26(5):743-9. Epub 2012 Dec 7.

Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/modpathol.2012.203DOI Listing
May 2013

A review of oral toxicity associated with mTOR inhibitor therapy in cancer patients.

Oral Oncol 2013 Apr 9;49(4):293-8. Epub 2013 Jan 9.

Department of Oral Pathology, School of Dentistry, University of São Paulo, São Paulo, Brazil.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.oraloncology.2012.11.008DOI Listing
April 2013

Adjuvant therapy for high-grade, uterus-limited leiomyosarcoma: results of a phase 2 trial (SARC 005).

Cancer 2013 Apr 18;119(8):1555-61. Epub 2013 Jan 18.

Department of Medicine, Gynecologic Medical Oncology Service, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cncr.27942
Publisher Site
http://dx.doi.org/10.1002/cncr.27942DOI Listing
April 2013

Loss of expression of SDHA predicts SDHA mutations in gastrointestinal stromal tumors.

Mod Pathol 2013 Feb 7;26(2):289-94. Epub 2012 Sep 7.

Dana-Farber Cancer Institute, Center for Sarcoma and Bone Oncology, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/modpathol.2012.153DOI Listing
February 2013

Cutaneous radiation-associated angiosarcoma of the breast: poor prognosis in a rare secondary malignancy.

Ann Surg Oncol 2012 Nov 14;19(12):3801-8. Epub 2012 Aug 14.

Department of Pathology, Brigham and Women's Hospital, Dana-Farber Cancer Institute, and Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-012-2563-4DOI Listing
November 2012

Regorafenib induces rapid and reversible changes in plasma nitric oxide and endothelin-1.

Am J Hypertens 2012 Oct 12;25(10):1118-23. Epub 2012 Jul 12.

Division of Nephrology, Department of Medicine, Boston Children's Hospital, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ajh.2012.97DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3578478PMC
October 2012

MED12 mutations in leiomyosarcoma and extrauterine leiomyoma.

Mod Pathol 2013 May 7;26(5):743-9. Epub 2012 Dec 7.

Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/modpathol.2012.203DOI Listing
May 2013

Uterine sarcomas: then and now.

AJR Am J Roentgenol 2012 Jul;199(1):213-23

Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, 20 Chapel St. Unit B401, Brookline, MA 02446, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2214/AJR.11.7287DOI Listing
July 2012

Intracranial metastasis from pediatric GI stromal tumor.

J Clin Oncol 2012 Apr 27;30(10):e122-5. Epub 2012 Feb 27.

Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2011.38.1798DOI Listing
April 2012

Recurrence patterns and survival for patients with intermediate- and high-grade myxofibrosarcoma.

Int J Radiat Oncol Biol Phys 2012 Jan 15;82(1):361-7. Epub 2010 Oct 15.

Harvard Radiation Oncology Program, Brigham and Women's Hospital, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2010.08.042DOI Listing
January 2012

Clinical presentation and management of mTOR inhibitor-associated stomatitis.

Oral Oncol 2011 Oct 3;47(10):998-1003. Epub 2011 Sep 3.

Department of Oral Pathology, School of Dentistry, University of São Paulo, São Paulo, Brazil.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.oraloncology.2011.08.009DOI Listing
October 2011

The role of imatinib plasma level testing in gastrointestinal stromal tumor.

Cancer Chemother Pharmacol 2011 Jan 8;67 Suppl 1:S45-50. Epub 2010 Dec 8.

Harvard Medical School, Clinical Director Center for Sarcoma and Bone Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-010-1527-2DOI Listing
January 2011

Mechanisms of resistance to imatinib and sunitinib in gastrointestinal stromal tumor.

Cancer Chemother Pharmacol 2011 Jan 24;67 Suppl 1:S15-24. Epub 2010 Dec 24.

Departments of Pathology, The University of Texas, M. D. Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-010-1513-8DOI Listing
January 2011

Personalized cancer therapy for gastrointestinal stromal tumor: synergizing tumor genotyping with imatinib plasma levels.

Curr Opin Oncol 2010 Jul;22(4):336-41

Center for Sarcoma and Bone Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CCO.0b013e32833a6b8eDOI Listing
July 2010

Cytoreductive surgery in patients with metastatic gastrointestinal stromal tumor treated with sunitinib malate.

Ann Surg Oncol 2010 Feb 7;17(2):407-15. Epub 2009 Nov 7.

Department of Surgery, Brigham and Women's Hospital, Dana-Farber Cancer Institute, and Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-009-0784-yDOI Listing
February 2010

Update on the treatment of gastrointestinal stromal tumors (GISTs): role of imatinib.

Biologics 2010 Feb 4;4:19-31. Epub 2010 Feb 4.

Visiting Fellow, Center for Sarcoma and Bone Oncology, Dana-Farber Cancer Institute, Boston, MA, USA;

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2819895PMC
http://dx.doi.org/10.2147/btt.s4396DOI Listing
February 2010

Predictive value of FIGO and AJCC staging systems in patients with uterine leiomyosarcoma.

Eur J Cancer 2009 Nov 31;45(16):2818-24. Epub 2009 Jul 31.

Department of Surgery, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, 75 Francis Street, Boston, MA 02115, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2009.06.030DOI Listing
November 2009

Recognition of a new chemotherapeutic vesicant: trabectedin (ecteinascidin-743) extravasation with skin and soft tissue damage.

J Clin Oncol 2009 Nov 5;27(33):e198-200. Epub 2009 Oct 5.

Division of Plastic Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2008.21.6473DOI Listing
November 2009

Secondary sarcomas after radiotherapy for breast cancer: sustained risk and poor survival.

Cancer 2009 Sep;115(18):4055-63

Department of Surgery, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.24462DOI Listing
September 2009

Gastrointestinal stromal tumor: a clinical overview.

Hematol Oncol Clin North Am 2009 Feb;23(1):69-78, viii

Center for Sarcoma and Bone Oncology, Dana-Farber Cancer Institute, 44 Binney Street, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.hoc.2008.11.006DOI Listing
February 2009

Multimodality treatment of mesenteric desmoid tumours.

Eur J Cancer 2008 Nov 14;44(16):2404-10. Epub 2008 Aug 14.

Department of Surgery, Brigham and Women's Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2008.06.038DOI Listing
November 2008